A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: Importance of the timing of butorphanol administration

Cephalalgia

Volumn 22, Issue 4, 2002, Pages 282-287

  Vachharajani, N N ^a   Shyu, W C ^a   Nichola, P S ^a   Boulton, David W ^a,b  

^a BRISTOL MYERS SQUIBB   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Butorphanol; Drug interaction; Nasal spray; Pharmacokinetics; Sumatriptan

Indexed keywords

BUTORPHANOL; BUTORPHANOL TARTRATE; STADOL NS7; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; NARCOTIC ANALGESIC AGENT; SEROTONIN AGONIST; VASOCONSTRICTOR AGENT;

ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; MIGRAINE; NEBULIZATION; VASOCONSTRICTION; ADULT; AEROSOL; AREA UNDER THE CURVE; DRUG ADMINISTRATION; DRUG INTERACTION; FEMALE; INTRANASAL DRUG ADMINISTRATION; MALE; RANDOMIZED CONTROLLED TRIAL; SAFETY;

ADMINISTRATION, INTRANASAL; ADULT; AEROSOLS; ANALGESICS, OPIOID; AREA UNDER CURVE; BUTORPHANOL; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; SAFETY; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0036560731     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2002.00359.x     Document Type: Article

References (17)

1. Kumar KL. Recent advances in the acute management of migraine and cluster headaches. J Gen Intern Med 1994; 9:339-48.
2. Tfelt-Hansen P. Drug treatment of migraine: acute treatment and migraine prophylaxis. Curr Opin Neurol 1996; 9:211-3.
3. Ziegler DK. Opioids in headache treatment. Is there a role? Neurol Clin 1997; 15:199-207.
4. Rosow CE. Butorphanol in perspective. Acute Care 1988; 12 (Suppl. 1):2-7.
5. Buzzi MG, Moskowitz MA. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 1991; 11:165-8.
6. de Hoon JN, Willigers JM, Troost J, Struijker-Boudier HA, Van Bortel LM. Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches. Clin Pharmacol Ther 2000; 68:418-26.
7. Imitex. [Product Information.] Research Triangle Park, NC: GlaxoWellcome Inc., 1994.
8. Liston H, Bennett L, Usher B, Nappi J. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman. Arch Intern Med 1999; 159:511-3.
9. Srinivas NR, Shyu WC, Upmalis D, Lee JS, Barbhaiya RH. Lack of pharmacokinetic interaction between butorphanol tartrate nasal spray and sumatriptan succinate. J Clin Pharmacol 1995; 35:432-7.
10. Boulton DW, Duncan GF, Vachharajani NN. Validation and application of a sensitive assay for butorphanol in human plasma by high-performance liquid chromatography with tandem mass spectroscopy detection. J Chromatogr 2002; in press.
11. Boulton DW, Duncan GF, Vachharajani NN. Validation and application of a high-performance liquid chromatography/tandem mass spectroscopy assay for sumatriptan in human plasma. J Chromatogr 2002; submitted.
12. Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications, 2nd edn. London: Lea and Febiger, 1989:9-461.
13. Ryan R, Elkind A, Baker CC, Mullican W, DeBussey S, Asghamejad M. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Neurology 1997; 49:1225-30.
14. Moore KHP, Hussay EK, Shaw A, Fuseau E, Duquesnoy C, Pakes GE. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses. Cephalalgia 1997; 17:541-50.
15. MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993; 87:401-5.
16. Gillis JC, Benfield P, Goa KL. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management. Drugs 1995; 50:157-75.
17. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headaches. Drugs 1994; 47:622-51.